In the U.S., CMS guidance from March 2024 allows Medicare Part D coverage of AOMs with medically accepted indications, such as diabetes or reducing the risk of major adverse cardiovascular events in patients with established cardiovascular disease
Taken together, the outcome of carnitine supplementation is not obvious for many IEMs, especially the organic acidemias, and to date, no studies have assessed the levels of TMAO in this population
Fraternale A, Paoletti MF, Casabianca A, Nencioni L, Garaci E, Palamara AT, Magnani M
Mirror Plastic Surgery monitors liver and cardiovascular markers with regular laboratory testing to support patient safety throughout treatment
However, the triggers and risk factors vary depending on the patients age
Diagnostic reliability of serum active B12 (holo-transcobalamin) in true evaluation of vitamin B12 deficiency: Relevance in current perspective